| Jessica Kendrick, MD | |
|
777 Bannock St, Denver, CO 80204-4507 | |
| (303) 436-6000 | |
| Not Available |
| Full Name | Jessica Kendrick |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 20 Years |
| Location | 777 Bannock St, Denver, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831245505 | NPI | - | NPPES |
| 75182726 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 45416 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Denver Dialysis (fmc) | Denver, CO | Dialysis facility |
| University Of Colorado Hospital Authority | Aurora, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians Incorporated | 3476465667 | 2657 |
News Archive
Activant Solutions Inc., a leading provider of retail and distribution business management solutions, today announced that Kopp Drug Inc. has selected the Activant Eagle® software platform to be its business management and Point-of-Sale solution. Kopp executives selected the Activant Eagle solution to help them improve inventory management and add operational efficiencies.
New research published in the scientific journal Thorax has found that smokers who undergo a CT scan of their lungs are more likely to quit smoking.
Research led by David Worthylake, PhD, Assistant Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, may help lay the groundwork for the development of a compound to prevent the spread of cancer. The research will be published in the May 29, 2009 issue of the Journal of Biological Chemistry.
Researchers at the University of Illinois Hospital & Health Sciences System have identified a genetic signature that distinguishes patients with complicated sarcoidosis, an inflammatory lung disease that can be fatal, from patients with a more benign form of the disease. The gene signature could become the basis for a simple blood test.
› Verified 9 days ago
| Entity Name | Denver Health And Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477569838 PECOS PAC ID: 4688583578 Enrollment ID: O20031105000211 |
News Archive
Activant Solutions Inc., a leading provider of retail and distribution business management solutions, today announced that Kopp Drug Inc. has selected the Activant Eagle® software platform to be its business management and Point-of-Sale solution. Kopp executives selected the Activant Eagle solution to help them improve inventory management and add operational efficiencies.
New research published in the scientific journal Thorax has found that smokers who undergo a CT scan of their lungs are more likely to quit smoking.
Research led by David Worthylake, PhD, Assistant Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, may help lay the groundwork for the development of a compound to prevent the spread of cancer. The research will be published in the May 29, 2009 issue of the Journal of Biological Chemistry.
Researchers at the University of Illinois Hospital & Health Sciences System have identified a genetic signature that distinguishes patients with complicated sarcoidosis, an inflammatory lung disease that can be fatal, from patients with a more benign form of the disease. The gene signature could become the basis for a simple blood test.
› Verified 9 days ago
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
Activant Solutions Inc., a leading provider of retail and distribution business management solutions, today announced that Kopp Drug Inc. has selected the Activant Eagle® software platform to be its business management and Point-of-Sale solution. Kopp executives selected the Activant Eagle solution to help them improve inventory management and add operational efficiencies.
New research published in the scientific journal Thorax has found that smokers who undergo a CT scan of their lungs are more likely to quit smoking.
Research led by David Worthylake, PhD, Assistant Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, may help lay the groundwork for the development of a compound to prevent the spread of cancer. The research will be published in the May 29, 2009 issue of the Journal of Biological Chemistry.
Researchers at the University of Illinois Hospital & Health Sciences System have identified a genetic signature that distinguishes patients with complicated sarcoidosis, an inflammatory lung disease that can be fatal, from patients with a more benign form of the disease. The gene signature could become the basis for a simple blood test.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Kendrick, MD 777 Bannock St, Denver, CO 80204-4507 Ph: (303) 436-6000 | Jessica Kendrick, MD 777 Bannock St, Denver, CO 80204-4507 Ph: (303) 436-6000 |
News Archive
Activant Solutions Inc., a leading provider of retail and distribution business management solutions, today announced that Kopp Drug Inc. has selected the Activant Eagle® software platform to be its business management and Point-of-Sale solution. Kopp executives selected the Activant Eagle solution to help them improve inventory management and add operational efficiencies.
New research published in the scientific journal Thorax has found that smokers who undergo a CT scan of their lungs are more likely to quit smoking.
Research led by David Worthylake, PhD, Assistant Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, may help lay the groundwork for the development of a compound to prevent the spread of cancer. The research will be published in the May 29, 2009 issue of the Journal of Biological Chemistry.
Researchers at the University of Illinois Hospital & Health Sciences System have identified a genetic signature that distinguishes patients with complicated sarcoidosis, an inflammatory lung disease that can be fatal, from patients with a more benign form of the disease. The gene signature could become the basis for a simple blood test.
› Verified 9 days ago
Katrina Wagoner-hursh, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1835 Franklin St, Denver, CO 80218 Phone: 303-338-4545 | |
Emily Martin Jones, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 8111 E Lowry Blvd, Denver, CO 80230 Phone: 720-848-0000 | |
Dr. Jesus Heliodoro Hermosillo Rodriguez, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2045 N Franklin St, Denver, CO 80205 Phone: 303-338-4545 | |
Margaret Hay, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1601 E 19th Ave Ste 3100, Denver, CO 80218 Phone: 303-863-0300 Fax: 303-863-7014 | |
Dr. Alan W Burgess, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1601 E 19th Ave Ste 6000, Denver, CO 80218 Phone: 303-861-7001 Fax: 303-861-8624 | |
Dr. Sahibzada Mohsin Shah, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 777 Bannock St, Denver, CO 80204 Phone: 303-436-6000 | |
Shyam M Parkhie, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 130 Rampart Way, 300b, Denver, CO 80230 Phone: 720-343-1562 Fax: 720-343-1563 |